Variant report
Variant | esv3369070 |
---|---|
Chromosome Location | chr5:29247195-29250293 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CDH6-9 | chr5:29247176-29247267 | l_2896_chr5:29228921-29247267_testes |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556553735 | chr5:29247236-29247237 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs149071954 | chr5:29247240-29247241 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs545404739 | chr5:29247258-29247259 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs560596739 | chr5:29247261-29247262 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs527784260 | chr5:29247371-29247372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4632810 | chr5:29247378-29247379 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs561071278 | chr5:29247387-29247388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557139854 | chr5:29247403-29247404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200600711 | chr5:29247421-29247422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112411035 | chr5:29247426-29247427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs72353166 | chr5:29247427-29247428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs5866920 | chr5:29247428-29247429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201870835 | chr5:29247429-29247430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545890173 | chr5:29247445-29247446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531357413 | chr5:29247458-29247459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562479379 | chr5:29247486-29247487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs75296331 | chr5:29247579-29247580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs571417427 | chr5:29247595-29247596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143069049 | chr5:29247599-29247600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546964279 | chr5:29247600-29247601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553966139 | chr5:29247611-29247612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs183183209 | chr5:29247612-29247613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187470160 | chr5:29247626-29247627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547836428 | chr5:29247641-29247642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs77209814 | chr5:29247659-29247660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs192973190 | chr5:29247661-29247662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556852666 | chr5:29247665-29247666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs578171261 | chr5:29247669-29247670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572919925 | chr5:29247673-29247674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs4346778 | chr5:29247701-29247702 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs184643324 | chr5:29247718-29247719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138546435 | chr5:29247731-29247732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140243773 | chr5:29247776-29247777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561636389 | chr5:29247779-29247780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561196115 | chr5:29247820-29247821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs11959636 | chr5:29247844-29247845 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs543237277 | chr5:29247869-29247870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11950848 | chr5:29247921-29247922 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs116480351 | chr5:29247934-29247935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs532267962 | chr5:29247935-29247936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs10056960 | chr5:29247964-29247965 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs75447003 | chr5:29247971-29247972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113123512 | chr5:29247987-29247988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138128633 | chr5:29247988-29247989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547899650 | chr5:29248013-29248014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs141764783 | chr5:29248015-29248016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs77150162 | chr5:29248068-29248069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189530736 | chr5:29248110-29248111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571949874 | chr5:29248122-29248123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs150572495 | chr5:29248124-29248125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29246000-29248600 | Enhancers | Hela-S3 | cervix |
2 | chr5:29247600-29248200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr5:29248600-29249400 | Weak transcription | Hela-S3 | cervix |
4 | chr5:29249400-29249600 | Enhancers | Hela-S3 | cervix |
5 | chr5:29249600-29250200 | Weak transcription | Hela-S3 | cervix |
6 | chr5:29250200-29250400 | Enhancers | Hela-S3 | cervix |